158 related articles for article (PubMed ID: 1465875)
1. Low-dose OKT3 for cadaveric renal transplantation.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
[No Abstract] [Full Text] [Related]
2. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
[No Abstract] [Full Text] [Related]
3. Role of maintenance immunosuppression and methylprednisolone in OKT3-induced cytokine release.
Peces R; Urra JM; Gorostidi M; López-Larrea C
Transplant Proc; 1992 Dec; 24(6):2596-9. PubMed ID: 1465877
[No Abstract] [Full Text] [Related]
4. Evidence for granulocyte activation by OKT3.
Schmaldienst S; Böhmig G; Pohanka E; Kovarik J; Zlabinger GJ
Transplant Proc; 1992 Dec; 24(6):2600-1. PubMed ID: 1465878
[No Abstract] [Full Text] [Related]
5. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
[No Abstract] [Full Text] [Related]
6. Cardiovascular effects of ATG and OKT3 in renal allograft recipients.
Spieker C; Barenbrock M; Buchholz B; Heidenreich S; Zidek W
Transplant Proc; 1992 Dec; 24(6):2594-5. PubMed ID: 1465876
[No Abstract] [Full Text] [Related]
7. Kidney transplantation in Slovenia from 1986 through 1991.
Kandus A; Buturović-Ponikvar J; Malovrh M; Bren AF
Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
[No Abstract] [Full Text] [Related]
8. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
[No Abstract] [Full Text] [Related]
9. DR6 compatibility and kidney graft survival.
Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
[No Abstract] [Full Text] [Related]
10. Pentamidine inhalation as a prophylaxis against Pneumocystis carinii pneumonia after therapy of acute renal allograft rejection with orthoclone (OKT3).
Spieker C; Barenbrock M; Tepel M; Buchholz B; Rahn KH; Zidek W
Transplant Proc; 1992 Dec; 24(6):2602-3. PubMed ID: 1465879
[No Abstract] [Full Text] [Related]
11. Area under the curve of cyclosporine pharmacokinetics: comparison of the characteristics of the pure drug and metabolites.
Foradori AC; Martínez L; Vacarezza A; Elberg A; Mella G; Loveluck A; Pinto C
Transplant Proc; 1992 Dec; 24(6):2614-5. PubMed ID: 1465884
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.
Morgan JD; Horsburgh T; Simpson A; Donnelly PK; Veitch PS; Bell PR
Transplant Proc; 1992 Dec; 24(6):2634-5. PubMed ID: 1334589
[No Abstract] [Full Text] [Related]
13. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
Norman DJ; Kahana L; Stuart FP; Thistlethwaite JR; Shield CF; Monaco A; Dehlinger J; Wu SC; Van Horn A; Haverty TP
Transplantation; 1993 Jan; 55(1):44-50. PubMed ID: 8420063
[TBL] [Abstract][Full Text] [Related]
14. Combined high and low dosing of OKT3 for treatment of rejection episodes in renal transplants.
Schweizer RT; Bartus S; Hull D; Perdrizet G; Roper L
Transplant Proc; 1994 Dec; 26(6):3141. PubMed ID: 7998094
[No Abstract] [Full Text] [Related]
15. Cyclosporine-related hypercoagulability: fact or fiction?
Edwards CM; Morgan JD; Donnelly PK
Transplant Proc; 1992 Dec; 24(6):2616-7. PubMed ID: 1465885
[No Abstract] [Full Text] [Related]
16. Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis.
Carrier M; Jenicek M; Pelletier LC
Transplant Proc; 1992 Dec; 24(6):2586-91. PubMed ID: 1465874
[No Abstract] [Full Text] [Related]
17. Enhanced renal graft survival in HLA-A mismatched transplants.
Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
[No Abstract] [Full Text] [Related]
18. Measures to improve early results in kidney transplantation.
Schweizer RT; Roper L; Hull D; Bartus S
Transplant Proc; 1992 Dec; 24(6):2729-30. PubMed ID: 1465919
[No Abstract] [Full Text] [Related]
19. Low-dose OKT3 induction therapy following renal transplantation leads to improved graft function and decreased adverse effects.
Brown M; Korb S; Light JA; Light T; Jonsson J; Aquino A
Transplant Proc; 1993 Feb; 25(1 Pt 1):553-5. PubMed ID: 8438411
[No Abstract] [Full Text] [Related]
20. Living-unrelated renal transplantation.
Simforoosh N; Bassiri A; Amiransari B; Gol S
Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
[No Abstract] [Full Text] [Related]
[Next] [New Search]